86 related articles for article (PubMed ID: 3312265)
1. Screening of antiviral drugs for hepadna virus infection in Pekin ducks: a review.
Zuckerman AJ
J Virol Methods; 1987 Aug; 17(1-2):119-26. PubMed ID: 3312265
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of the polybasic anion, suramin and acyclovir in Hepadna virus infection.
Tsiquaye KN; Collins P; Zuckerman AJ
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():223-8. PubMed ID: 3793662
[TBL] [Abstract][Full Text] [Related]
3. Postexposure treatment of experimental DHBV infection: a new therapeutic strategy.
Freiman JS; Murray SM; Vickery K; Lim D; Cossart YE
J Med Virol; 1990 Apr; 30(4):272-6. PubMed ID: 2142501
[TBL] [Abstract][Full Text] [Related]
4. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
Sherker AH; Hirota K; Omata M; Okuda K
Gastroenterology; 1986 Oct; 91(4):818-24. PubMed ID: 2943628
[TBL] [Abstract][Full Text] [Related]
5. Screening of antiviral drugs for treatment of hepatitis B.
Tsiquaye KN; Collins P; Zuckerman AJ
J Hepatol; 1986; 3 Suppl 2():S45-8. PubMed ID: 2955032
[No Abstract] [Full Text] [Related]
6. Effects of acyclovir and vidarabin 5'-monophosphate on anti-duck hepatitis B virus in an in vitro culture system.
Motegi K
J Gastroenterol; 1995 Apr; 30(2):224-30. PubMed ID: 7539683
[TBL] [Abstract][Full Text] [Related]
7. Suramin prevents duck hepatitis B virus infection in vivo.
Offensperger WB; Offensperger S; Walter E; Blum HE; Gerok W
Antimicrob Agents Chemother; 1993 Jul; 37(7):1539-42. PubMed ID: 8363388
[TBL] [Abstract][Full Text] [Related]
8. Suramin inhibits duck hepatitis B virus DNA polymerase activity.
Tsiquaye K; Zuckerman A
J Hepatol; 1985; 1(6):663-9. PubMed ID: 4056360
[TBL] [Abstract][Full Text] [Related]
9. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
Le Guerhier F; Thermet A; Guerret S; Chevallier M; Jamard C; Gibbs CS; Trépo C; Cova L; Zoulim F
J Hepatol; 2003 Mar; 38(3):328-34. PubMed ID: 12586299
[TBL] [Abstract][Full Text] [Related]
10. Duck hepatitis B virus model for screening of antiviral agents from medicinal herbs.
Mi Z; Chen H; Zhang X; Shao X; Li Z; Wu X
Chin Med J (Engl); 1995 Sep; 108(9):660-4. PubMed ID: 8575230
[TBL] [Abstract][Full Text] [Related]
11. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
Foster WK; Miller DS; Scougall CA; Kotlarski I; Colonno RJ; Jilbert AR
J Virol; 2005 May; 79(9):5819-32. PubMed ID: 15827196
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
Chen Y; Guo S; Qi Z; Huang A
Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):209-11. PubMed ID: 11602049
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
Noordeen F; Scougall CA; Grosse A; Qiao Q; Ajilian BB; Reaiche-Miller G; Finnie J; Werner M; Broering R; Schlaak JF; Vaillant A; Jilbert AR
PLoS One; 2015; 10(11):e0140909. PubMed ID: 26560490
[TBL] [Abstract][Full Text] [Related]
15. In vivo study of the mechanism of action of antiviral agents against hepadna virus replication in the liver. Resistance of supercoiled viral DNA.
Omata M; Hirota K; Yokosuka O
J Hepatol; 1986; 3 Suppl 2():S49-55. PubMed ID: 2439576
[TBL] [Abstract][Full Text] [Related]
16. A technique for liver biopsy in Pekin ducks.
Bacher J; Kassianides C; Moskal TJ; Mathews DM; Hoofnagle JH
Lab Anim Sci; 1989 Jan; 39(1):67-8. PubMed ID: 2918689
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
18. M13 bacteriophage DNA inhibits duck hepatitis B virus during acute infection.
Iizuka A; Watanabe T; Kubo T; Yamamoto M; Ogawa K; Ohkuma T; Kaji A
Hepatology; 1994 May; 19(5):1079-87. PubMed ID: 8175129
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
[TBL] [Abstract][Full Text] [Related]
20. Effect of alcohol extract of Acanthus ilicifolius L. on anti-duck hepatitis B virus and protection of liver.
Wei PH; Wu SZ; Mu XM; Xu B; Su QJ; Wei JL; Yang Y; Qin B; Xie ZC
J Ethnopharmacol; 2015 Feb; 160():1-5. PubMed ID: 25446633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
